Diagnosis of thyroid disease using deep convolutional neural network models applied to thyroid scintigraphy images: a multicenter study

Abstract

ObjectivesThe aim of this study was to improve the diagnostic performance of nuclear medicine physicians using a deep convolutional neural network (DCNN) model and validate the results with two multicenter datasets for thyroid disease by analyzing clinical single-photon emission computed tomography (SPECT) image data.MethodsIn this multicenter retrospective study, 3194 SPECT thyroid images were collected for model training (n=2067), internal validation (n=514) and external validation (n=613). First, four pretrained DCNN models (AlexNet, ShuffleNetV2, MobileNetV3 and ResNet-34) for were tested multiple medical image classification of thyroid disease types (i.e., Graves’ disease, subacute thyroiditis, thyroid tumor and normal thyroid). The best performing model was then subjected to fivefold cross-validation to further assess its performance, and the diagnostic performance of this model was compared with that of junior and senior nuclear medicine physicians. Finally, class-specific attentional regions were visualized with attention heatmaps using gradient-weighted class activation mapping.ResultsEach of the four pretrained neural networks attained an overall accuracy of more than 0.85 for the classification of SPECT thyroid images. The improved ResNet-34 model performed best, with an accuracy of 0.944. For the internal validation set, the ResNet-34 model showed higher accuracy (p < 0.001) when compared to that of the senior nuclear medicine physician, with an improvement of nearly 10%. Our model achieved an overall accuracy of 0.931 for the external dataset, a significantly higher accuracy than that of the senior physician (0.931 vs. 0.868, p < 0.001).ConclusionThe DCNN-based model performed well in terms of diagnosing thyroid scintillation images. The DCNN model showed higher sensitivity and greater specificity in identifying Graves’ disease, subacute thyroiditis, and thyroid tumors compared to those of nuclear medicine physicians, illustrating the feasibility of deep learning models to improve the diagnostic efficiency for assisting clinicians.

Artificial intelligence-driven prognostic system for conception prediction and management in intrauterine adhesions following hysteroscopic adhesiolysis: a diagnostic study using hysteroscopic images

“…This has significant implications for clinical decision-making and patient counseling. The adoption of the CPH neural network architecture provides several advantages over conventional transfer learning models for medical image classification ( Li et al, 2023b ; Zhao et al, 2023 ). Firstly, it enables the prediction of time-to-event outcomes, such as the probability of conception over time.…”

Artificial Intelligence in Healthcare: 2023 Year in Review

“…Imaging publications continue to focus on various imaging modalities including interpretation of X-rays, CT scans, MRIs and ultrasounds [10][11][12]. Majority of this research work utilizes deep learning, more specifically and not unexpectedly convolutional neural networks [13,14]. There were a few publications which focus on optimizing image processing and clinician workflows [15].…”

A narrative review of deep learning in thyroid imaging: current progress and future prospects

“…Most of the above-mentioned models have focused exclusively on the benign and malignant classification of individual thyroid nodules, while other common disorders, such as hyperthyroidism, hypothyroidism, and thyroiditis, have received insufficient attention ( 5 ). Functional thyroid diseases are often insidious, and their early symptoms can be nonspecific, leading to a delay in diagnosis ( 110 ). US imaging can indicate the presence of abnormal thyroid parenchyma but cannot assess changes in thyroid function.…”

“…A modified DenseNet architecture was tested for categorizing Graves disease, Hashimoto thyroiditis, and subacute thyroiditis ( 51 ). Moreover, a deep CNN-based model was reported to perform well in identifying Graves disease, subacute thyroiditis, and thyroid tumors ( 110 ).…”